Healthcare / Health Information ServicesBSE
$2.22
+0.01 (+0.45%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-245973.57 · quality 46.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$320M
P/E
4.9x
↓EV/EBITDA
10.1x
↓ROE
3.9%
↑Gross Margin
88.5%
↑Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-3.3%
FCF CAGR
-84.7%
FCF margin
14.9%
FCF / Net income
0.21x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $12.6M · net income $8.8M · FCF $1.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $12.6M | $12.6M | $25.6M | $76.7M | $13.9M |
| Net Income | $8.8M | $8.8M | $4.2M | $12.6M | $2.0M |
| EBITDA | $11.9M | $11.9M | $7.8M | $18.5M | $2.7M |
| EPS | 0.17 | 0.17 | 0.13 | 3.10 | 0.06 |
| Gross Margin | 88.5% | 88.5% | 64.5% | 41.7% | 30.2% |
| Operating Margin | 35.3% | 35.3% | 31.4% | 21.0% | 0.1% |
| Net Margin | 69.6% | 69.6% | 16.3% | 16.4% | 14.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.08 | 0.26 | — |
| Current Ratio | 19.34 | 19.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.9M | $1.9M | $-54.3M | $-245973.57 | $518.4M |
| Returns | |||||
| ROE | 3.9% | 3.9% | 2.0% | 8.5% | 2.6% |
| Valuation | |||||
| P/E | 4.93 | 4.93 | 47.73 | 3.34 | 27.28 |
| EV/EBITDA | 10.12 | 10.12 | 42.88 | 28.03 | 16.54 |
| P/B | 0.52 | 0.52 | 1.57 | 3.66 | 0.71 |
| Growth & Yield | |||||
| Revenue Growth | -50.7% | -50.7% | -66.7% | 451.0% | — |
| EPS Growth | 28.6% | 28.6% | -95.8% | 5319.4% | — |
| Dividend Yield | 9.1% | 9.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
5.8%
EPS terminal req.
$0.20
Spread vs growth
22.7%
5Y implied EPS CAGR
7.5%
EPS terminal req.
$0.24
Spread vs growth
21.1%
10Y implied EPS CAGR
8.7%
EPS terminal req.
$0.38
Spread vs growth
19.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-45.7%
Start / end P/E
38.0x → 13.4x
EPS bridge
0.13 → 0.17
Residual
-18.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.